AUTOMATED DELIVERY OF A THERAPEUTIC OR COSMETIC SUBSTANCE TO CUTANEOUS, SUBCUTANEOUS AND INTRAMUSCULAR TISSUE REGIONS
First Claim
1. A method for transcutaneous delivery of a flowable therapeutic or cosmetic substance to a cutaneous, subcutaneous or intramuscular tissue region, comprising:
- maneuvering an automated arm to position a delivery device mounted on the automated arm proximate a targeted location on a patient'"'"'s skin surface; and
using a substantially automated process to (i) cause a tissue-piercing distal end of the delivery device to puncture the skin surface and penetrate a desired depth in the tissue at the targeted location, and (ii) deliver a controlled dose of the therapeutic or cosmetic substance into the tissue at the targeted location through the delivery device.
8 Assignments
0 Petitions
Accused Products
Abstract
Automated systems and methods for delivery of a therapeutic or cosmetic substance into cutaneous, subcutaneous or intramuscular tissue, wherein an automated (e.g., robotic) arm is maneuvered to position a delivery device proximate a targeted location (e.g., an existing hair follicle, a location for implanting a skin filler, or a location for intradermal tattoo ink injection) on a patient'"'"'s skin surface; and a substantially automated process is used to cause the delivery device to puncture the skin surface and penetrate to a desired depth into the tissue at the targeted location, and deliver the substance therein.
-
Citations
62 Claims
-
1. A method for transcutaneous delivery of a flowable therapeutic or cosmetic substance to a cutaneous, subcutaneous or intramuscular tissue region, comprising:
-
maneuvering an automated arm to position a delivery device mounted on the automated arm proximate a targeted location on a patient'"'"'s skin surface; and using a substantially automated process to (i) cause a tissue-piercing distal end of the delivery device to puncture the skin surface and penetrate a desired depth in the tissue at the targeted location, and (ii) deliver a controlled dose of the therapeutic or cosmetic substance into the tissue at the targeted location through the delivery device. - View Dependent Claims (2, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 19)
-
- 3. (canceled)
-
11. (canceled)
-
18. (canceled)
-
20-21. -21. (canceled)
-
22. An automated system for transcutaneous delivery of a therapeutic or cosmetic substance into a cutaneous, subcutaneous or intramuscular tissue region, comprising:
-
an automated arm; a delivery device mounted on the automated arm; one or more cameras [mounted on the automated arm]; a processor configured to receive and process images acquired by the one or more cameras; and a controller operatively associated with the processor and configured to maneuver the automated arm based, at least in part, on images acquired by the one or more cameras and processed by the processor, wherein the automated arm is maneuverable such that the delivery device may be positioned proximate a targeted location on a patient'"'"'s skin surface, and one or both of the processor and controller configured to cause (i) a distal end of the delivery device to puncture the skin surface and penetrate into tissue at the targeted location, and (ii) a controlled delivery through the delivery device of a therapeutic or cosmetic substance into the tissue. - View Dependent Claims (23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)
-
-
34. A method for delivery of a therapeutic or cosmetic substance to cutaneous or subcutaneous tissue of, or proximate to, an existing hair follicle in a body surface of a patient, comprising:
-
maneuvering an automated arm to position a delivery device mounted on the automated arm proximate a targeted hair follicle in the body surface; and using a substantially automated process to (i) cause a tissue-piercing distal end of the delivery device to puncture the skin surface and penetrate a desired depth into cutaneous or subcutaneous tissue at least partially surrounding, or otherwise proximate to, the hair follicle, and (ii) deliver a therapeutic or cosmetic substance into the tissue. - View Dependent Claims (38, 48, 49)
-
-
35-37. -37. (canceled)
-
39-47. -47. (canceled)
-
50-53. -53. (canceled)
-
54. An automated system for transcutaneous delivery of a therapeutic or cosmetic cellular or pharmacological matter into a cutaneous, subcutaneous or intramuscular tissue region, comprising:
-
an automated arm; a cellular or pharmacological matter delivery device carried by the automated arm; one or more cameras; a processor configured to receive and process images acquired by the one or more cameras; and a controller operatively associated with the processor and configured to maneuver the automated arm based, at least in part, upon images acquired by the one or more cameras and processed by the processor, wherein the automated arm is maneuverable such that the cellular or pharmacological matter delivery device may be positioned proximate a targeted location on a patient'"'"'s body surface, and one or both of the processor and controller are configured to cause a controlled delivery through the cellular or pharmacological matter delivery device of a therapeutic or cosmetic cellular or pharmacological matter into the tissue at the targeted location. - View Dependent Claims (55, 56, 57, 58, 59, 60)
-
-
61. An automated system for transcutaneous delivery of a therapeutic or cosmetic substance into a cutaneous, subcutaneous or intramuscular tissue region, comprising:
-
an automated arm; a delivery device carried by the automated arm; a controller configured to maneuver the automated arm and to cause a controlled delivery through the delivery device of a therapeutic or cosmetic substance into the tissue at the targeted location; and a user interface operably coupled to the controller, wherein the user interface allows a system operator to input instructions relating to one or more of a location of the delivery device, an orientation of the delivery device, a penetration depth of the delivery device, a type of the therapeutic or cosmetic substance to be delivered into a targeted tissue region, and a quantity of the therapeutic or cosmetic substance to be delivered into a targeted tissue region. - View Dependent Claims (62)
-
Specification